Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

View source ↗

Summary

This clinical trial update indicates a study evaluating weekly subcutaneous semaglutide for weight loss in adolescents with monogenic obesity, currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Prof. Dr. Martin Wabitsch | Conditions: Monogenic Obesity | Status: RECRUITING